PROPIONATE DE FLUTICASONE/SALMETEROL TEVA RESPIHALER 250 micrograms/50 micrograms/dose, powder for inhalation in a single-dose container 60 single-dose containers
Active ingredients: Fluticasone propionate, Salmeterol, Salmeterol xinafoate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for inhalation60 single-dose containersinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROPIONATE DE FLUTICASONE/SALMETEROL TEVA RESPIHALER 250 microgrammes/50 microgrammes/dose, poudre pour inhalation en récipient unidose
- Pharmaceutical form
- poudre pour inhalation
- Route of administration
- inhalée
- Presentation description
- 1 plaquette(s) aluminium de 60 récipient(s) unidose(s) avec distributeur(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63313268CIP73027276CIP133400930272763Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROPIONATE DE FLUTICASONEpoudre | 250 microgrammes · une dose | SA |
| SALMÉTÉROLpoudre | 50 microgrammes · une dose | FT |
| XINAFOATE DE SALMÉTÉROLpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.